<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>1 </plain></SENT>
<SENT sid="1" pm="."><plain>Current studies indicate that nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) plays a dual role as both a protective and pathogenic factor in focal <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> depending on the level, location, source and environment </plain></SENT>
<SENT sid="2" pm="."><plain>The present study hypothesized that the NO donor ZJM-289 could inhibit <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e>-reperfusion (I/R) injury and investigated the mechanism of the beneficial events </plain></SENT>
<SENT sid="3" pm="."><plain>2 </plain></SENT>
<SENT sid="4" pm="."><plain>Adult male rats were randomly divided into four groups: (i) sham operated; (ii) I/R (<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> for 90 min and reperfusion for 24 h) treated with vehicle; (iii) I/R treated with 0.1 mmol/kg body weight ZJM-289; and (iv) I/R treated with 0.2 mmol/kg body weight ZJM-289 </plain></SENT>
<SENT sid="5" pm="."><plain>We evaluated the changes in <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e>, brain-water content, neurological deficits and histopathology </plain></SENT>
<SENT sid="6" pm="."><plain>Western blot analysis was used to study the expression of endothelial nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (eNOS) and neuronal nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (nNOS) in the brain after I/R </plain></SENT>
<SENT sid="7" pm="."><plain>The levels of NO and cyclic <z:chebi fb="0" ids="16750">guanosine</z:chebi> monophosphate (cGMP) were also determined </plain></SENT>
<SENT sid="8" pm="."><plain>3 </plain></SENT>
<SENT sid="9" pm="."><plain>ZJM-289 reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and brain-water content in ischemic brains and promoted functional recovery </plain></SENT>
<SENT sid="10" pm="."><plain>Western blotting showed significant inhibition of nNOS in ZJM-289 treated rats compared with untreated rats </plain></SENT>
<SENT sid="11" pm="."><plain>However, eNOS expression in the ischemic brain was enhanced in the ZJM-289 groups </plain></SENT>
<SENT sid="12" pm="."><plain>The cGMP and NO levels increased in the ZJM-289 groups after I/R </plain></SENT>
<SENT sid="13" pm="."><plain>The study showed that ZJM-289 could alleviate cerebral injury after I/R through inhibition of nNOS and stimulation of the NO/soluble guanylate cyclase/cGMP pathway </plain></SENT>
<SENT sid="14" pm="."><plain>Therefore, a suitable NO donor might be an effective candidate for the treatment of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> by neuroprotection </plain></SENT>
</text></document>